NO970081L - Fremgangsmåte for folding av proteiner som rekombinant hirudin eller epidermisk vekstfaktor - Google Patents
Fremgangsmåte for folding av proteiner som rekombinant hirudin eller epidermisk vekstfaktorInfo
- Publication number
- NO970081L NO970081L NO970081A NO970081A NO970081L NO 970081 L NO970081 L NO 970081L NO 970081 A NO970081 A NO 970081A NO 970081 A NO970081 A NO 970081A NO 970081 L NO970081 L NO 970081L
- Authority
- NO
- Norway
- Prior art keywords
- growth factor
- epidermal growth
- recombinant hirudin
- folding proteins
- correctly folded
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet en fremgangsmåte for fremstilling av et biologisk aktivt og korrekt foldet protein i nærvær av denatureringsmidler som urea eller guanidinhydro-klorid og separasjon av det korrekt foldede proteinet direkte derfra. Fremgangsmåten kan f.eks. anvendes ved renaturering av rekombinante proteiner som hirudln eller epidermisk vekstfaktor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94810437 | 1994-07-25 | ||
| PCT/EP1995/002720 WO1996003425A1 (en) | 1994-07-25 | 1995-07-12 | Process for folding of proteins like recombinant hirudin or epidermal growth factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970081L true NO970081L (no) | 1997-01-09 |
| NO970081D0 NO970081D0 (no) | 1997-01-09 |
Family
ID=8218291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970081A NO970081D0 (no) | 1994-07-25 | 1997-01-09 | Fremgangsmåte for folding av proteiner som rekombinant hirudin eller epidermisk vekstfaktor |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0804461A1 (no) |
| JP (1) | JPH11505507A (no) |
| AU (1) | AU3109795A (no) |
| CA (1) | CA2194177A1 (no) |
| FI (1) | FI970230A7 (no) |
| IL (1) | IL114699A0 (no) |
| NO (1) | NO970081D0 (no) |
| WO (1) | WO1996003425A1 (no) |
| ZA (1) | ZA956137B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3734634B2 (ja) | 1999-03-03 | 2006-01-11 | ヒゲタ醤油株式会社 | タンパク質の活性化方法及び該装置 |
| US7521479B2 (en) | 2001-04-16 | 2009-04-21 | Panacea Pharmaceuticals, Inc. | Methods of treating prion disease in mammals |
| WO2003097669A2 (en) * | 2002-05-17 | 2003-11-27 | Københavns Universitet | Method for purifying denatured proteins having a desired disulfide bond configuration |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR79124B (no) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
| ES8800957A1 (es) * | 1985-02-22 | 1987-12-01 | Monsanto Co | Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina |
| GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| JP3200850B2 (ja) * | 1991-02-26 | 2001-08-20 | 味の素株式会社 | ヒトbcdfの精製法 |
| US5290920A (en) * | 1992-04-16 | 1994-03-01 | Allelix Biopharmaceuticals Inc. | Method of purifying human epidermal growth factor |
-
1995
- 1995-07-12 AU AU31097/95A patent/AU3109795A/en not_active Abandoned
- 1995-07-12 CA CA002194177A patent/CA2194177A1/en not_active Abandoned
- 1995-07-12 JP JP8505402A patent/JPH11505507A/ja active Pending
- 1995-07-12 EP EP95926859A patent/EP0804461A1/en not_active Withdrawn
- 1995-07-12 FI FI970230A patent/FI970230A7/fi not_active Application Discontinuation
- 1995-07-12 WO PCT/EP1995/002720 patent/WO1996003425A1/en not_active Ceased
- 1995-07-24 ZA ZA956137A patent/ZA956137B/xx unknown
- 1995-07-24 IL IL11469995A patent/IL114699A0/xx unknown
-
1997
- 1997-01-09 NO NO970081A patent/NO970081D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11505507A (ja) | 1999-05-21 |
| CA2194177A1 (en) | 1996-02-08 |
| NO970081D0 (no) | 1997-01-09 |
| IL114699A0 (en) | 1995-11-27 |
| EP0804461A1 (en) | 1997-11-05 |
| AU3109795A (en) | 1996-02-22 |
| FI970230A0 (fi) | 1997-01-20 |
| WO1996003425A1 (en) | 1996-02-08 |
| ZA956137B (en) | 1996-03-07 |
| FI970230L (fi) | 1997-01-20 |
| FI970230A7 (fi) | 1997-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960309L (fi) | Neisseria meningitidis, B-ryhmän ulkomembraanin poriiniproteiinien korkean tason ilmentäminen, puhdistaminen ja uudelleenlaskostaminen | |
| EE03590B1 (et) | Peptiidide ja proteiinide aerosoolvormid | |
| DE3686654D1 (de) | Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form. | |
| NO950461L (no) | Enterisk sammensetning innbefattende naturlig micellært kasein | |
| DE69007975D1 (de) | Fusionsprotein bestehend aus gm-csf und il-3. | |
| IL92012A0 (en) | Process for the activation of gene-technologically produced proteins expressed in prokaryotes | |
| ATE339878T1 (de) | Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung | |
| AU583723B2 (en) | Process for renaturing of proteins | |
| NO970081L (no) | Fremgangsmåte for folding av proteiner som rekombinant hirudin eller epidermisk vekstfaktor | |
| FI924746A7 (fi) | Kohydrolyysimenetelmä uusien uutteiden valmistamiseksi hiiva- ja ei-hi ivaproteiineista | |
| DE68919848D1 (de) | Amphiphile peptide und deren verwendung. | |
| DE69836626D1 (de) | Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung | |
| ES2168282T3 (es) | D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion. | |
| ATE261985T1 (de) | Verfahren zur herstellung von richtig gefaltetem, biologisch aktivem, rekombinantem protein | |
| DE59109261D1 (de) | Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung | |
| DE59503776D1 (de) | Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung | |
| MX9700658A (es) | Proceso para el plegamiento de proteinas como hirudina recombinante o factor de crecimiento epidermico. | |
| ATE216706T1 (de) | Peptide des hiv-gag proteins, ihre herstellung und verwendung | |
| DE69121489D1 (de) | In vitro-Behandlung von Fusionsproteinen | |
| DE58907746D1 (de) | Verfahren zur Bestimmung von Fructosamin. | |
| FI905985L (fi) | Menetelmä somatotropiinien saamiseksi liukoisiksi ja naturoimiseksi käyttämällä alhaista urean konsentraatiota | |
| NO961995L (no) | Anvendelse av IGF-BP for renaturering av IGF | |
| WO1997041207A3 (en) | Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector | |
| DE59006998D1 (de) | Verfahren zur herstellung von hirudin. | |
| ATA166890A (de) | Rekombinantes dna-molekül für allergene des erlenpollens, damit hergestellte proteine bzw. polypeptide, sowie deren anwendung |